Research Reports
Explore our comprehensive catalog of market intelligence across 60+ industries
Pharmaceutical Market: Patent Cliffs and Blockbuster Pipeline
Pharmaceutical industry revenue reached $1.82T globally in 2024 with emerging market growth (11.2% YoY) outpacing developed markets (3.1%). Patent cli...
Dr. Michael Foster
Feb 20, 2025
Direct-to-Consumer (DTC) Pharmaceutical Marketing: Regulatory and Commercial
Direct-to-consumer pharmaceutical advertising spending reached $9.2B in 2024 with digital channels capturing 68% of budget. DTC campaigns influenced 3...
Dr. Sophia Taylor
Feb 12, 2025
Rare Disease and Orphan Drug Development: Market Opportunities
Rare disease drug approvals reached 48 in 2024, representing 75% of all FDA drug approvals. Orphan drug market reached $280B with average peak sales o...
Dr. Isabella Rodriguez
Feb 05, 2025
Generic and Biosimilar Market: Regulatory Pathways and Competition
Biosimilar approvals reached 184 globally by 2024 with EU leading adoption at 18% of biologic prescriptions. Generic drug penetration reached 84% of p...
Dr. Klaus Weber
Jan 25, 2025
Drug Discovery and AI: Computational Chemistry and Target Identification
AI-powered drug discovery platforms advanced with 28 clinical candidates originating from AI-identified leads by 2024. Virtual screening capabilities ...
Dr. Patricia Johnson
Jan 15, 2025
Combination Therapies and Drug-Device Integration: Enhanced Efficacy
Fixed-dose combination (FDC) drugs represented 18% of new drug approvals in 2024, improving patient compliance 24-32%. Drug-device combination product...
Dr. Margot Chen
Jan 12, 2025
Pharmacogenomics and Personalized Dosing: Drug Response Optimization
Pharmacogenomic testing adoption reached 24% of prescription drugs in developed markets by 2024. Personalized dosing based on genetic profiles improve...
Dr. James Wong
Dec 28, 2024
Clinical Trial Efficiency: Decentralized Trials and Patient Recruitment
Decentralized clinical trial adoption reached 34% of new trials by 2024, reducing enrollment timelines 25-40% and improving retention by 18%. Patient ...
Dr. Sarah Martinez
Dec 10, 2024
Manufacturing and Supply Chain: Pharma Production Optimization
Pharma manufacturing investments reached $34.2B in 2024 driven by supply chain resilience initiatives following COVID-19 disruptions. Continuous manuf...
Dr. Emma Mueller
Nov 20, 2024
Infectious Disease Treatments: Antibiotic Resistance and New Therapeutics
Antibiotic resistance deaths reached 1.27M globally in 2024 creating urgent demand for new therapeutics. Antibiotic development received increased fun...
Dr. Hans Bergman
Nov 15, 2024